Fig. 5From: Transcatheter arterial chemoembolization plus sorafenib versus transcatheter arterial chemoembolization alone to treat advanced hepatocellular carcinoma: a meta-analysisForest plot comparing toxicity (hand-foot skin reaction, hypertension, diarrhoea, fatigue, hepatotoxicity, myelosuppression and rash). CI, confidence interval; RR, risk ratio; Combination group, TACE + sorafenib; and Control group, TACE aloneBack to article page